Ironwood Pharmaceuticals Q3 Adj. EPS $0.24 Beats $0.10 Estimate, Sales $122.060M Beat $74.701M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.10 by 140 percent. This is a 1100 percent increase over earnings of $0.02 per share
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.10 by 140 percent. This is a 1100 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $122.060 million which beat the analyst consensus estimate of $74.701 million by 63.40 percent. This is a 33.26 percent increase over sales of $91.592 million the same period last year.